Malignant Hyperthermia Flashcards

1
Q

What is the primary treatment for malignant hyperthermia?

A

Dantrolene sodium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False: Malignant hyperthermia is a rare, life-threatening condition triggered by certain drugs used during anesthesia.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action of dantrolene sodium in treating malignant hyperthermia?

A

It inhibits calcium release from the sarcoplasmic reticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the recommended dose of dantrolene sodium for treating malignant hyperthermia?

A

2.5 mg/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the initial step in the treatment of malignant hyperthermia?

A

Stop administration of triggering agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the role of cooling measures in the treatment of malignant hyperthermia?

A

To prevent further heat production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the purpose of administering intravenous fluids in the treatment of malignant hyperthermia?

A

To maintain adequate hydration and electrolyte balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the importance of continuous monitoring of vital signs during treatment of malignant hyperthermia?

A

To detect and manage any complications promptly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the potential complication of malignant hyperthermia if not treated promptly?

A

Rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the significance of genetic testing for malignant hyperthermia susceptibility?

A

To identify individuals at risk before anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of the Malignant Hyperthermia Association of the United States (MHAUS) in the management of malignant hyperthermia?

A

To provide resources and support for patients and healthcare providers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main goal of treatment in malignant hyperthermia?

A

To rapidly reverse the hypermetabolic state and stabilize the patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the recommended treatment approach for managing malignant hyperthermia crisis?

A

Administer dantrolene sodium, cool the patient, and provide supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the potential consequence of delayed treatment of malignant hyperthermia?

A

Increased risk of morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the primary cause of malignant hyperthermia?

A

A genetic mutation in the ryanodine receptor gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the role of the healthcare team in the management of malignant hyperthermia?

A

Collaborate to provide prompt and effective treatment

17
Q

What is the significance of a thorough patient history in the context of malignant hyperthermia?

A

To identify potential triggers and risk factors

18
Q

What is the recommended approach for prevention of malignant hyperthermia in susceptible individuals?

A

Avoid triggers such as certain anesthetics and succinylcholine

19
Q

What is the importance of educating patients and families about malignant hyperthermia?

A

To raise awareness and prompt early recognition of symptoms

20
Q

What is the role of muscle biopsy in diagnosing malignant hyperthermia susceptibility?

A

To confirm genetic predisposition in uncertain cases

21
Q

What is the significance of rapid intervention in malignant hyperthermia?

A

To prevent severe complications and organ damage

22
Q

What is the recommended follow-up care for patients who have experienced malignant hyperthermia?

A

Genetic counseling and avoidance of triggering agents in future anesthesia

23
Q

What is the primary focus of nursing care for a patient with malignant hyperthermia?

A

Monitoring vital signs and assisting with cooling measures

24
Q

What is the expected outcome of prompt and appropriate treatment of malignant hyperthermia?

A

Full recovery without long-term sequelae